EP Patent

EP3366685A1 — Tryptoline derivatives having kinase inhibitory activity and uses thereof

Assigned to X Chem Inc · Expires 2018-08-29 · 8y expired

What this patent protects

The present invention features tryptoline derivatives and related compounds having kinase inhibitory activity. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions, suc…

USPTO Abstract

The present invention features tryptoline derivatives and related compounds having kinase inhibitory activity. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions, such as cancers, inflammatory disorders, or autoimmune disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP3366685A1
Jurisdiction
EP
Classification
—
Expires
2018-08-29
Drug substance claim
No
Drug product claim
No
Assignee
X Chem Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.